United Capital Financial Advisers, LLC Cumberland Pharmaceuticals Inc Transaction History

United Capital Financial Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.93 - $3.03 $31,354 - $49,225	-16,246 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.73 - $6.4 $2,677 - $3,622	-566 Reduced 3.37%	16,246 $96,000
Q2 2019 Aug 13, 2019	BUY	$5.35 - $6.8 $1,112 - $1,414	208 Added 1.25%	16,812 $107,000
Q1 2019 May 14, 2019	SELL	$5.06 - $6.5 $111 - $143	-22 Reduced 0.13%	16,604 $96,000
Q4 2017 Feb 13, 2018	SELL	$6.79 - $7.96 $135,800 - $159,200	-20,000 Reduced 54.61%	16,626 $123,000
Q2 2017 Aug 14, 2017	BUY	N/A	36,626	36,626 $259,000

1.97M

44.2K

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $33.7M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.